A physician-scientist and MIT–Novo Nordisk AI Fellow specializing in precision neuroscience, aging, and preventive therapeutics. His work advances biologically grounded precision-prevention strategies in Alzheimer’s disease by combining translational clinical research with large-scale multi-omic analytics and foundation AI models. At the Department of Mechanical Engineering at MIT, and at the Broad Institute of MIT and Harvard, he develops computational frameworks that decode coherent molecular signatures of neurodegeneration, enabling improved patient stratification, optimized treatment delivery, and more efficient translation of biomarkers into scalable clinical care.